Review
Published on 20 Dec 2019
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01408
- 8,985 views
- 18 citations
Type at least 3 characters
1,011 articles
Articles
Original Research
Published on 18 Dec 2019
Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01406
- 8,184 views
- 41 citations
Case Report
Published on 18 Dec 2019
Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01437
- 7,849 views
- 15 citations
Review
Published on 03 Dec 2019
Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01356
- 50,496 views
- 59 citations
Original Research
Published on 15 Nov 2019
CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01201
- 12,968 views
- 115 citations
Original Research
Published on 12 Nov 2019
Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01202
- 2,880 views
- 18 citations
Original Research
Published on 12 Nov 2019
Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01220
- 5,333 views
- 30 citations
Case Report
Published on 08 Nov 2019
Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01180
- 6,388 views
- 2 citations
Review
Published on 08 Nov 2019
Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01153
- 9,562 views
- 70 citations
Review
Published on 24 Oct 2019
Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01104
- 16,657 views
- 86 citations
Original Research
Published on 22 Oct 2019
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01110
- 5,974 views
- 23 citations
Review
Published on 15 Oct 2019
The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01073
- 10,428 views
- 33 citations
Original Research
Published on 15 Oct 2019
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01015
- 5,572 views
- 50 citations
Original Research
Published on 03 Oct 2019
Development of Triptolide Self-Microemulsifying Drug Delivery System and Its Anti-tumor Effect on Gastric Cancer Xenografts
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00978
- 3,247 views
- 14 citations
Review
Published on 02 Oct 2019
Convection-Enhanced Delivery: Connection to and Impact of Interstitial Fluid Flow
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00966
- 15,202 views
- 78 citations
Original Research
Published on 02 Oct 2019
Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00993
- 4,757 views
- 28 citations